<DOC>
	<DOCNO>NCT02724384</DOCNO>
	<brief_summary>The purpose study evaluate safety preliminary efficacy use electrical plasma treat toenail fungus .</brief_summary>
	<brief_title>Evaluating Safety , Tolerability Preliminary Efficacy Plasma Improving Appearance Onychomycosis</brief_title>
	<detailed_description>75 patient recruit several site . Patients split 3 group different treatment dos . Patient participation study last 12 month .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>1 . Subject must 18 70 year age inclusive , either sex , race ; 2 . Subject must distal subungual infection affect approximately 25 % 60 % least one great toenail 3 . Dermatophyte infection infection C. Albicans target great toenail confirm identification dermatophyte organism culture ; 4 . Subject must least 3 mm proximal end target toenail free infection ; 5 . Subject must target toenail assess capable grow approximately 1 mm/month , ( e.g. , subject need report cut toenail least per month ) ; 6 . Subject must willing give write informed consent able adhere procedure visit schedule ; 7 . Subject must consent toenail photograph study period ; 8 . Woman childbearing potential : If currently sexually active , must agree use medically accept method contraception receive protocolspecified medication 30 day stop study treatment ; If currently active , must agree use medically accept method contraception become sexually active study participation . Methods include condom ( male female ) without spermicidal agent , diaphragm cervical cap spermicide , medically prescribe intrauterine device , oral systemic hormonal contraceptive ( plus additional reliable barrier method ) , surgical sterilization ( e.g. , hysterectomy tubal ligation ) ; 9 . Woman childbearing potential must negative serum urine pregnancy test prior start study . 1 . Subject 6 infect toenail 2 . Subject fingernail onychomycosis 3 . Subject one follow condition primary target toenail : 1. white superficial onychomycosis 2. dermatophytoma `` yellow spike/streak '' 3. primarily lateral bilateral disease 4. toenail thickness great 3 mm 5. inability become normal opinion investigator 4 . Subject psoriasis , pincer nail , prior nail surgery , severe moccasintype tinea pedis require treatment , symptomatic interdigital tinea pedis , lichen planus , abnormality could result clinically abnormal nail ; 5 . Subject peripheral vascular disease peripheral circulatory impairment ; 6 . Subject uncontrolled diabetes mellitus , subject diabetes controlled insulin know diabetic peripheral neuropathy 7 . Subject known immunodeficiency ; 8 . Any pacemaker , metallic implant prostheses vicinity treatment site ( ankle , foot , etc . ) ; 9 . Subject clinically significant condition situation , condition study , opinion investigator , would interfere study evaluation optimal participation study ; 10 . Subject receive systemic antifungal therapy within 6 month ( except single diflucan tablet vaginal candida ) topical antifungal therapy apply foot toenail within 1 month study entry ; 11 . Subject receive radiation therapy , chemotherapy , and/or immunosuppressive drug within 6 month study , and/or oral corticosteroid &gt; 1 month within 6 month study ( exception : inhaled steroid ) ; 12 . Subject know received treatment investigational drug device within 30 day prior enrollment study ; 13 . Subject unwilling abstain cosmetic nail foot treatment outside provide study clinic , beyond basic nail trimming ( i.e . spa foot treatment , pedicures/toenail polish use , topical prescription toenail medication ) ; 14 . Woman breastfeed , pregnant , intend become pregnant ( check via urine test ) ; 15 . Subject part staff personnel directly involve study family member investigational study staff ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>